New-Onset Transilent Hallucinations Possibly Due To Eszopiclone: A Case Study
Open accessAbstract
Sir: Catatonia is a clinical syndrome characterized by alterations in motor behavior and changes in thought, mood, and vigilance 1 and occurs in a variety of medical and neuropsychiatric conditions. 2 Catatonia has been documented as occurring in alcohol withdrawal in rodents, 3 but not in humans.We report the case of a patient in whom alcohol withdrawal presented as catatonia.Case report.Mr. A, aged 35 years, presented in January 2006 with a history of alcohol use over the last 10 years.He fulfilled the DSM-IV criteria for alcohol dependence for the last 5 years.He presented with tremors, irritability, anorexia, and insomnia within 24 hours of abrupt cessation of alcohol intake.Seventy-two hours after cessation of alcohol intake, he developed signs of negativism, mutism, and psychomotor agitation lasting 2 days, followed by psychomotor retardation, stereotypies, and stupor over the next 2 days, fulfilling DSM-IV criteria for catatonia.There were no psychotic or mood symptoms, clouding of consciousness, disorientation, or any general medical condition that could explain these symptoms.He had experienced a similar episode 2 years previous, following 3 days of abstinence from alcohol, that remitted upon treatment with lorazepam.Family history was positive for alcohol dependence in first-and second-degree relatives but was negative for psychotic or mood disorders.The findings of laboratory investigations were within normal limits.As the patient's condition could not be described adequately by DSM-IV criteria for alcohol withdrawal or catatonia, the diagnosis of alcohol-induced psychotic disorder was made, with onset during alcohol withdrawal and presenting with catatonia.Mr. A was treated with lorazepam 16 mg per day and with vitamin supplements.His symptoms remitted completely within 72 hours.Catatonia has been documented in alcohol dependence in relation to drug interactions involving disulfiram 4 and in delirium. 1 The temporal correlation between alcohol abstinence and the appearance of catatonia in the absence of these other causes suggests that the catatonia in this case was due to alcohol withdrawal.Perturbations in γaminobutyric acid (GABA)-ergic and glutamatergic transmission have been implicated in the pathophysiology of both catatonia 2 and alcohol withdrawal. 5,6 Furthermore, the GABA A modulator lorazepam is effective in both conditions. 1,7 To our knowledge, this case is the first such case reported in the literature.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There are still relatively few studies investigating substance use disorder associated with eszopiclone.
“There are still relatively few studies 29 investigating substance use disorder associated with eszopiclone.”
From Z-drug abuse and dependence: Clinical guideline of the Brazilian Academy of Neurology for diagnosis and management (2025) · cites this paper as [29]
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139 · see citing works
(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · see citing works
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550 · see citing works
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473 · see citing works
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,340 · see citing works
Mcevoy, J., Meyer, J., Goff, D., Nasrallah, H., Davis, S., Sullivan, L., Meltzer, H., Hsiao, J. K., Stroup, T., & Lieberman, J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,220 · see citing works
Compulsive buying: a report of 20 cases.
McElroy, S. L., Keck, P. E., Pope, H. G., Smith, J., & Strakowski, S. M. (1994) · PubMed · Cited by 646 · see citing works
Catatonia in Psychiatric Classification: A Home of Its Own
Taylor, M. A., & Fink, M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1233 · Cited by 581 · see citing works
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 502 · see citing works
Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder
GELLER, D. A., Biederman, J., Stewart, S. E., Mullin, B. C., Martin, A., Spencer, T. J., & Faraone, S. V. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1919 · Cited by 433 · see citing works
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416 · see citing works
Depression and Obstructive Sleep Apnea (OSA)
Schroder, C. M., & O'Hara, R. M. (2005) · Annals of General Psychiatry · doi:10.1186/1744-859x-4-13 · Cited by 275 · see citing works
Central Nervous System Side Effects Associated with Zolpidem Treatment
Toner, L. C., Tsambiras, B. M., Catalano, G., Catalano, M. C., & Cooper, D. S. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00011 · Cited by 273 · see citing works
Wade, A. G., Lemming, O. M., & Hedegaard, K. B. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00001 · Cited by 232 · see citing works
ROTH, T., WALSH, J., KRYSTAL, A., WESSEL, T., & ROEHRS, T. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.06.004 · Cited by 230 · see citing works
Glutamate-mediated transmission, alcohol, and alcoholism
Dodd, P. R., Beckmann, A. M., Davidson, M. S., & Wilce, P. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00061-9 · Cited by 214 · see citing works
Circadian Rhythm Sleep Disorders
Zisapel, N. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00005 · Cited by 212 · see citing works
Hypothyroidism and depression. Evidence from complete thyroid function evaluation
Gold, M. S. (1981) · JAMA · doi:10.1001/jama.245.19.1919 · Cited by 204 · see citing works
Montgomery, S., Kasper, S. F., Stein, D. J., Hedegaard, K. B., & Lemming, O. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00002 · Cited by 184 · see citing works
Mechanisms of action of current and potential pharmacotherapies of obsessive–compulsive disorder
El Mansari, M., & Blier, P. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.005 · Cited by 142 · see citing works
Use of large medical databases to study associations between diseases
Goldacre, M. J., Kurina, L. M., Yeates, D., Seagroatt, V. A., & Gill, L. (2000) · QJM · doi:10.1093/qjmed/93.10.669 · Cited by 106 · see citing works
A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder
Kaplan, A., & Hollander, E. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.8.1111 · Cited by 105 · see citing works
Brown, E. S., Vigil, L., Khan, D. A., Liggin, J. D. M., Carmody, T. J., & Rush, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.030 · Cited by 99 · see citing works
Depression in Asthma: Prevalence and Clinical Implications
Zielinski, T., Brown, S., Nejtek, V. A., Kahn, D. A., Moore, J. J., & Rush, A. J. (2000) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v02n0501 · Cited by 95 · see citing works
Markowitz, J. S., & Brewerton, T. D. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609148806 · Cited by 92 · see citing works
The catatonic dilemma expanded
Penland, H. R., Weder, N. D., & Tampi, R. R. (2006) · Annals of General Psychiatry · doi:10.1186/1744-859x-5-14 · Cited by 84 · see citing works
Zolpidem-Associated Hallucinations and Serotonin Reuptake Inhibition: A Possible Interaction
Elko, C. J., Burgess, J. L., & Robertson, W. O. (1998) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659809028939 · Cited by 80 · see citing works
Zolpidem-Related Effects on Performance and Mood During Simulated Night-Shift Work.
Hart, C. L., Ward, A. S., Haney, M., & Foltin, R. W. (2003) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.11.4.259 · Cited by 67 · see citing works
(2005) · Humana Press eBooks · doi:10.1385/1-59259-944-3:063 · Cited by 56 · see citing works
The euthyroid sick syndrome: Is there a physiologic rationale for thyroid hormone treatment?
Stathatos, N., & Wartofsky, L. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03349153 · Cited by 52 · see citing works
A Novel Clinical Pattern of Visual Hallucination After Zolpidem Use
Tsai, M., Huang, Y., & Wu, P. (2003) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120025354 · Cited by 47 · see citing works
Escitalopram: A Second-Generation SSRI
Owens, M. J., & Rosenbaum, J. F. (2002) · CNS Spectrums · doi:10.1017/s1092852900028583 · Cited by 41 · see citing works
Tolerability of ziprasidone: an expanding perspective.
Daniel, D. G. (2003) · PubMed · Cited by 37 · see citing works
Outpatient detoxification of the addicted or alcoholic patient.
Prater, C. D., Miller, K. E., & Zylstra, R. G. (1999) · PubMed · Cited by 36 · see citing works
Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy
Cocito, L., Maffini, M., & Loeb, C. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90022-1 · Cited by 36 · see citing works
l-NAME precipitates catatonia during ethanol withdrawal in rats
Uzbay, T. I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00332-6 · Cited by 35 · see citing works
Depression and Obstructive Sleep Apnea in Patients With Coronary Heart Disease
Carney, R. M., Howells, W. B., Freedland, K. E., Duntley, S. P., Stein, P. K., Rich, M. W., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000204632.91178.26 · Cited by 30 · see citing works
Perceptual Disturbances With Zaleplon
Bhatia, S. C., Arora, M., & Bhatia, S. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.1.109-a · Cited by 30 · see citing works
Ziprasidone: a novel psychotropic with unique properties
Ballas, C. A., Yang, C., O’Reardon, J. P., Ballas, P., & Baldassano, C. F. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.2.179 · Cited by 26 · see citing works
Venlafaxine-Induced Hypomanic Switch in Bipolar Depression
Gupta, N. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600815 · Cited by 22 · see citing works
Catatonic reaction to omeprazole and disulfiram in a patient with alcohol dependence.
Hajela, R., Cunningham, G. M., Kapur, B., Peachey, J. E., & Devenyi, P. (1990) · Europe PMC (PubMed Central) · Cited by 19 · see citing works
Lambert, O., Veyrac, G., Armand, C., Bourlon, S., Bourin, M., & Jolliet, P. (2002) · Adverse Drug Reactions and Toxicological Reviews · doi:10.1007/bf03256191 · Cited by 15 · see citing works
Venlafaxine-Associated Hypomania in Unipolar Depression
Chand, P., Kalyani, G. S., & Murthy, P. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900717 · Cited by 15 · see citing works
Jensen, J., Nolan, G., & Jubiz, W. (1978) · Journal of Endocrinological Investigation · doi:10.1007/bf03350367 · Cited by 14 · see citing works
Antidepressant-Induced Mania and Cycle Acceleration: A Controversy Revisited
Altshuler, L. L., Leberich, G. S., Mikalauskas, K., ROSOFF, A. S., & Ackerman, L. (2019) · Routledge eBooks · doi:10.4324/9781315054308-11 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The clinical and forensic toxicology of Z-drugs
Gunja, N. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0292-0 · Cited by 230 · see citing works
Rösner, S., Englbrecht, C., Wehrle, R., Hajak, G., & Soyka, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010703.pub2 · Cited by 60 · see citing works
Non-Benzodiazepine Receptor Agonists for Insomnia.
Becker, P., & Somiah, M. (2015) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2014.11.002 · Cited by 32 · see citing works
Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia
Najib, J. S. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_18 · Cited by 9 · see citing works
Birnie, K., Stewart, R. J., & Kolliakou, A. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-025216 · Cited by 5 · see citing works
Gussow, L., & Carlson, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00163-8 · Cited by 3 · see citing works
New-Onset Visual Hallucinations With Eszopiclone
McGuire, J. M., Duquette, M., Burghart, S. M., & Ferri, M. (2016) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15l01859 · Cited by 2 · see citing works
Stelzer, F. G., Bacelar, A., Éckeli, A. L., Negrão, A. B., Almeida, C. M. O., Franco, C. M. R., Pires, G. N., Gitaí, L. L. G., Sobreira-Neto, M. A., Assis, M., et al. (2025) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0045-1812323 · Cited by 1 · see citing works
Insomnia: A Review of the Use of Eszopiclone
Dautovich, N. D., Williams, J. M., & McCrae, C. S. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s1940
- Authors
- Duggal, H. S.
- Corresponding author
- Duggal, Harpeet S.
- Venue
- The Primary Care Companion to The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-12-14
- Volume
- 09
- Issue
- 06
- Pages
- 468-469
- ISSN
- 1523-5998 (ISSN-L)
- PMC
- PMC2139930
- OpenAlex
- W2086350574
- Cited by
- 10
- References
- 47
- Citations by year
- 2025: 2 · 2018: 2 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion to The Journal of Clinical Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Neurology › Alcoholism and Thiamine Deficiency
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Keywords
- catatonia, alcohol withdrawal, alcoholism, eszopiclone, lorazepam, GABAergic neurotransmission, glutamatergic neurotransmission, benzodiazepine treatment, stupor, mutism, psychomotor agitation, stereotypy, negativism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
